dc.contributor.author | Shestakova, M. V. | |
dc.contributor.author | Satman, I. | |
dc.contributor.author | Piletic, M. | |
dc.contributor.author | Leiter, L. A. | |
dc.contributor.author | Trubitsyna, N. P. | |
dc.date.accessioned | 2021-03-03T11:54:53Z | |
dc.date.available | 2021-03-03T11:54:53Z | |
dc.identifier.citation | Trubitsyna N. P. , Shestakova M. V. , Piletic M., Satman I., Leiter L. A. , "Implementing an optimised glucose-lowering strategy in daily medical practice with first- and second-line gliclazide MR 60 mg", 51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Stockholm, İsveç, 14 - 18 Eylül 2015, cilt.58 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_2abc8854-67d4-430c-97de-3e5180dadaf4 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/33493 | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Endokrinoloji ve Metabolizma Hastalıkları | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp | |
dc.subject | ENDOKRİNOLOJİ VE METABOLİZMA | |
dc.title | Implementing an optimised glucose-lowering strategy in daily medical practice with first- and second-line gliclazide MR 60 mg | |
dc.type | Bildiri | |
dc.contributor.department | Inst Diabet Mellitus , , | |
dc.identifier.volume | 58 | |
dc.contributor.firstauthorID | 147628 | |